Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 243 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-WARFARIN | 1MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-26 | 224589 |
APO-TADALAFIL | 10MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-26 | 225790 |
APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-11-10 | 2024-04-26 | 209957 |
APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-03-01 | 2024-04-26 | 221090 |
APO-PROPAFENONE | 150MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223049 |
APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2024-04-12 | 2024-04-26 | 224993 |
APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223055 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-09 | 2024-04-26 | 219171 |
APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2024-04-12 | 2024-04-26 | 225014 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223083 |
APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2024-03-27 | 2024-04-26 | 223558 |
APO-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-04-23 | 216693 |
APO-GLICLAZIDE | 80MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225799 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-04-19 | 225779 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-04-19 | 225770 |
APO-TRIMEBUTINE | 100MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225767 |
APO-FUROSEMIDE | 20MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223067 |
APO-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221720 |
APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221678 |
APO-KETOROLAC | 10MG | TABLET | Resolved | 2024-03-01 | 2024-04-19 | 221102 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |